COVID-19: Vaccines and Therapeutics
The federal government continues to learn lessons about distributing COVID-19 therapeutics, such as remdesivir, Food and Drug Administration Commissioner Stephen Hahn, M.D., said at a Senate Health, Education, Labor and Pensions Committee hearing.
The National Institutes of Health's National Institute of Allergy and Infectious Diseases released a strategic plan for accelerating research to diagnose, prevent and treat COVID-19.
The Department of Health and Human Services will partner with more than a dozen biopharmaceutical companies and the European Medicines Agency to prioritize vaccine and drug candidates, streamline clinical trials and coordinate regulatory processes to respond to the pandemic, the National Institutes…
The Department of Health and Human Services said it will speed the development and manufacturing of vaccines to prevent COVID-19, starting a candidate from Johnson & Johnson subsidiary Janssen Research & Development.
FDA said it is partnering with the European Medicines Agency (EMA) on regulatory strategies to facilitate the development of COVID-19 vaccines.
Congressional leaders today reached a deal on an $8.3 billion spending package to combat the novel coronavirus (COVID-19). The House passed the bill this afternoon, and the Senate is expected to take it up soon.
Select highlights of the package follow.
The AHA and American Nurses Association today urged Congress to “swiftly provide” $1 billion in initial supplemental emergency funding to support the “urgent preparedness and response needs of hospitals, health systems, physicians and nurses on the front lines” of the novel coronavirus outbreak.